-
nRichDX Launches New CTC Enrichment Kit
The Revolution CTC Enrichment Kit (Epithelial Cell Origin)™ is nRichDX’s latest product to advance liquid biopsy development.IRVINE, Calif., Sept. 29, 2023 /PRNewswire/ — nRichDX® has launched its new RUO-labeled CTC enrichment kit that uniquely isolates Circulating Tumor Cells (CTCs) from up to 40mL of whole blood samples to help researchers advance liquid biopsy assay research
-
Debbie’s Dream Foundation: Curing Stomach Cancer Launches the 2023 Youth Art Contest: Igniting Young Minds Against Stomach Cancer
DDF encourages young artists to spark their creativity while joining the fight against stomach cancer. FORT LAUDERDALE, Fla., Sept. 29, 2023 /PRNewswire/ — Debbie’s Dream Foundation: Curing Stomach Cancer (DDF) is thrilled to announce the return of the 2023 Youth Art Contest. This initiative encourages artists aged 18 and under to unleash their creativity and
-
Anbio Biotechnology to Present at AACC Middle East 2023 on October 7th, 2023
FRANKFURT, Germany, Sept. 28, 2023 /PRNewswire/ — Anbio Biotechnology (“Anbio”), a leading global diagnostic device and assay company, has announced its participation in the AACC Middle East 2023 in Dubai on October 7-8, 2023. Middle East is a significant region for healthcare and medical laboratory and Anbio is looking forward to establishing more business cooperation with
-
Insights From HumanFirst Show Breadth of Pharmaceutical Investment in AI/ML and Digital Endpoints in Clinical Trials
For the first time, HumanFirst Institute’s analysis puts numbers to the digital biomarker and clinical outcome assessment (COA) revolution happening in life sciences SAN FRANCISCO, Sept. 28, 2023 /PRNewswire/ — Regulators are increasingly approving AI-powered endpoints using digital health technologies (DHTs) in drug development. To quantify this trend, HumanFirst, life science’s first cloud-based platform for
-
Renowned Cardiovascular Researcher Dr. Eva Lonn Joins Premier Clinical Trial Network
HAMILTON, ON, Sept. 27, 2023 /PRNewswire/ — Premier Clinical Trial Network (PCTN), a leading clinical research and site management organization, is thrilled to announce the addition of distinguished researcher Dr. Eva Lonn to its team of principal investigators. Continue Reading Doctor Eva Lonn Headshot Dr. Lonn is joining PCTN seeking new opportunities to conduct groundbreaking
-
RedSail Technologies and LSPedia Announce Full Platform Integration with OneScan Pharmacy Pro – A Seamless Fusion of Pharmacy Management and DSCSA Compliance at Special Pricing
FARMINGTON HILLS, Mich., Sept. 26, 2023 /PRNewswire/ — LSPedia, the forefront traceability solution provider, and RedSail Technologies, a pinnacle in pharmacy software and services, are thrilled to announce their partnership aimed at giving dispensers a top-tier, holistic solution for pharmacy management and Drug Supply Chain Security Act (DSCSA) compliance. Continue Reading RedSail Technologies, a trusted
-
Medical Vein Clinic Announces Opening of Second San Antonio Facility to Meet Patient Demand
The specialized10,000-square-foot clinic in Northwest San Antonio will add 50 medical professional positions SAN ANTONIO, Sept. 26, 2023 /PRNewswire/ — Medical Vein Clinic announced the opening of a second clinic in Northwest San Antonio, expanding their services to meet burgeoning patient demand for state-of-the-art treatments for vein disease and lymphedema. The spa-like10,000+-square-foot clinic will add 50
-
ValGenesis Announces Astrix as Validation Partner for North America and Europe
SANTA CLARA, Calif., Sept. 26, 2023 /PRNewswire/ — ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Astrix, a digital transformation and specialized services company, have partnered to provide regulatory advisory and validation services alongside the ValGenesis product suite for life sciences companies across North America and Europe. For over 25
-
NVIGEN Pioneers Breakthrough in High-Resolution Tissue RNA Sequencing with Magnetic Nanoparticle Capture from Nanopipetting Aspiration of Minuscule Single Cell Contents
SANTA CLARA, Calif., Sept. 26, 2023 /PRNewswire/ — NVIGEN, a leading provider of modern nanoparticle solutions to empower revolutionary personalized healthcare, announces its new application in RNA sequencing (RNAseq) that promises to transform our understanding of cellular dynamics within tissues. Continue Reading NVIGEN X – Precision Medicine Biomarker Profling NGS snd Multiomics Test NVIGEN NERNST-Seq:
-
CHA Announces Rebrand and Launches New Website
CHAsolutions.com Expresses CHA’s Longstanding Commitment to Finding A Better Way ALBANY, N.Y. , Sept. 26, 2023 /PRNewswire/ — CHA Consulting, Inc. (CHA), an innovative, full-service engineering, design, consulting, and program/construction management firm, announces a strategic brand refresh and the launch of its new website at https://www.chasolutions.com/. Building on its impressive portfolio of innovative work, the refreshed brand
